Astrazeneca

FromAstraZeneca ([email protected])
Subject (116)New study results reinforce Tagrisso as the backbone therapy for EGFR-mutated lung cancer across stages and settings
Preheader (47)͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏
Typography
Arial
Colors
Text Analysis
Body Words244
Subject Words17
Body Emojis1
Subject Emojis
Media Analysis
Text Links8
Image Links4
Total Links12
Images7
Technical Metrics
Performance
HTML Size, Kb
Pixel Length, px752 px
X-Spam Score1.0
Preheader OptimizedNo
Timing
Day of WeekFriday
TimeAfternoon

New study results reinforce Tagrisso as the backbone therapy for EGFR-mutated lung cancer across stages and settings

͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏
New study results reinforce Tagrisso as the backbone therapy for EGFR-mutated lung cancer across stages and settings